Prism is an FDA‑cleared, non‑medication treatment designed for individuals who have not improved with traditional options. It uses EEG‑guided neurofeedback to retrain emotional and cognitive pathways associated with PTSD and depression.
A New Approach To Emotional And Cognitive Reset
Prism targets specific neural circuits involved in PTSD and depression. The EEG cap tracks your brain activity while you engage in structured tasks designed to reduce overactive fear responses or strengthen motivation and emotional regulation. Over time, these repeated exercises help reinforce more stable patterns, supporting measurable improvements in daily functioning.
Prism helps retrain fear‑based responses, reducing hypervigilance, emotional reactivity, and intrusive patterns.
Prism strengthens circuits related to motivation, engagement, and emotional stability, supporting improved mood and daily functioning.
Duration
8‑week program
2 sessions per week
30 minutes
In‑office, supervised
A Calm, Structured, And Guided Experience. Sessions are quiet, focused, and supervised. You’ll wear an EEG cap, complete guided tasks, and receive real‑time feedback. Side effects are minimal and typically limited to temporary fatigue or mild emotional shifts. Results vary, and progress is monitored throughout the program.
Prism’s EEG‑guided neurofeedback has demonstrated meaningful improvements in PTSD and depression symptoms. FDA clearance is supported by structured clinical trials and consistent outcomes across the eight‑week program.
Compliance & Patient Rights Your information is protected, and your care follows strict clinical and privacy standards defined by our Privacy Policy, HIPAA Notice, Telehealth Consent, and Terms of Service.
